The biologics market is growing rapidly and is on track to be worth $719.14 bn by 2030, up from $366.6 bn in 2021.¹ This growth …
An Introduction to Oral Solid Dose Traditionally, the pharmaceutical market has been dominated by oral drug delivery – whether oral solid dose (OSD) or liquid …
The new sterile area at the Aenova site in Latina, Italy, goes into commercial production end of October 2021. This first phase of an around …
Updates 2018 Full Year and Second Quarter Financial Guidance Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has received $47 million as a result of signing …
Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has established a new agreement with clinical-stage gene therapy company, MeiraGTx. …
Vetter, one of the global leaders in prefilled drug-delivery systems, today announced the official opening of a new branch office in South Korea. The new …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
